Last reviewed · How we verify
NCT03682913
Personalized Inhibitory Control Training for Compulsive Behavior Change
NA trial testing P-CIT protocol in OCD in 50 participants. Status unknown.
30 July 2019
Quick facts
| Lead sponsor | Hebrew University of Jerusalem |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 July 2018 |
| Primary completion | 30 July 2019 |
| Estimated completion | 30 August 2019 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- P-CIT protocol
- Placebo
Conditions studied
- OCD — all drugs for OCD →
Sponsor
Hebrew University of Jerusalem
Who can join
18 and older, any sex, with OCD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Obsessive-compulsive disorder (OCD) is a severe mental illness characterized by repetitive behaviors that a person feels compelled to perform. It has been demonstrated that stimuli in the environment can trigger the compulsive urge, perpetuating the OCD cycle. The main goal of the current proposal, which is based on exciting pilot data, is to test a novel computerized training program to create an association between OCD-related stimuli, which typically trigger the compulsive urge, and the brain system responsible for stopping. The idea is that once this system is triggered, it will be easier for patients to stop the compulsive urge.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03682913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for OCD
Currently open trials in the same condition.
- NCT06934525 — Implementing Team-Based Treatment for Pediatric Anxiety in Community Mental Health Settings · NA · recruiting
- NCT06282146 — Testing a Transdiagnostic TMS Treatment Target · EARLY_PHASE1 · active not recruiting
- NCT05994053 — Neuromodulation for a Novel OCD Biomarker and Treatment · NA · recruiting
- NCT06978452 — Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories · recruiting
- NCT06731426 — Multi-session, Personalized Cognitive Bias Modification for Thought-Action-Fusion · NA · recruiting
Other Hebrew University of Jerusalem trials
Trials by the same sponsor.
- NCT07003282 — A Study to Test Feasibility and Acceptability of an Intervention Program Aiming to Reduce Prenatal Secondhand Smoke Expo · NA · recruiting
- NCT05771545 — Telepsychiatry to Enable Expedited Disposition of Psychiatric Emergencies · active not recruiting
- NCT05447091 — Examining the Effectiveness of a Tablet Video Game on Mood and Cognition · NA · completed
- NCT04697316 — Transcranial Direct Current Stimulation (tDCS) as a Cognitive Functioning Enhancement Treatment for ADHD Patients Compar · NA · completed
- NCT07025603 — Evaluation of the Social ABCs in Israel · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03682913 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hebrew University of Jerusalem
- Last refreshed: 27 September 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03682913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing